Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain

PHASE3RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

July 3, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2027

Conditions
Degenerative Disc Disease
Interventions
DRUG

Rexlemestrocel-L + HA mixture

Rexlemestrocel-L will be combined in 1:1 by-volume ratio with HA solution and the resulting mixture will be administered as intradiscal injection.

DRUG

Saline

Saline solution injection adjacent to the index disc.

Trial Locations (39)

14611

RECRUITING

University of Rochester, Rochester

17402

RECRUITING

OSS Health, York

21401

RECRUITING

The Kahan Center, Annapolis

23238

RECRUITING

VA iSpine Physicians, Richmond

27704

RECRUITING

Eximia EquiHealth Research LLC/Emerge Ortho, Durham

28792

RECRUITING

AdventHealth Hendersonville, Hendersonville

29406

RECRUITING

Clinical Trials of South Carolina, Charleston

30265

RECRUITING

Vista Clinical Research, Newnan

30338

RECRUITING

Emory Healthcare, Dunwoody

32162

RECRUITING

Interventional Pain Institute, The Villages

32224

RECRUITING

Bold City Clinical Research, Jacksonville

32789

RECRUITING

Conquest Research LLC, Winter Park

33012

RECRUITING

New Life Medical Research Center, Hialeah

33306

RECRUITING

Cantor Spine Center at the Paley Orthopedic & Spine Institute, Fort Lauderdale

33569

RECRUITING

Florida Spine & Pain Specialists, Riverview

41017

RECRUITING

Iqra Research, Edgewood

45432

RECRUITING

Meta Medical Research Institute, LLC, Dayton

46307

RECRUITING

Lakeshore Bone and Joint, Crown Point

66160

RECRUITING

University of Kansas Medical Center, Kansas City

70458

RECRUITING

Paradigm Health System, Slidell

73034

RECRUITING

Clinical Investigations, LLC, Edmond

77030

RECRUITING

Paradigm Research Center/Houston Scoliosis and Spine Institute, Houston

77584

RECRUITING

Axsendo Clinical Research/Texas Institute of Pain and Spine, Pearland

78414

RECRUITING

Institute of Precision Pain Medicine, Corpus Christi

80111

RECRUITING

Colorado Spine Partners/The Denver Spine and Pain Institute, Greenwood

83702

RECRUITING

The Pain Centre, Inc., Boise

85085

RECRUITING

Axsendo Clinical Research/Summa Pain Care, Phoenix

89511

RECRUITING

Reno Tahoe Pain Associates, Reno

90403

RECRUITING

Source Healthcare, Santa Monica

90806

RECRUITING

Memorial Orthopaedic Surgical Group, Long Beach

91910

RECRUITING

TriWest Research Associates, Chula Vista

92111

RECRUITING

Innovative Pain Treatment Solutions, San Diego

92660

RECRUITING

Newport Therapeutics, Newport Beach

94143

RECRUITING

University of California-San Francisco, San Francisco

94520

RECRUITING

Boomerang Health Care, Concord

95816

RECRUITING

University of California-Davis Spine Center, Sacramento

96734

RECRUITING

Hawaii Pain & Spine, Kailua

97201

RECRUITING

Axsendo Clinical Research/Compass Pain and Wellness, Portland

02903

RECRUITING

Rhode Island Hospital, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mesoblast, Ltd.

INDUSTRY

NCT06325566 - Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain | Biotech Hunter | Biotech Hunter